Peer reviewed publications and conference

abstracts of my research conducted at the

University of Oxford, Eli Lilly, Pfizer and Flatiron Health

  • "Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England"

    —BMC Publication

  • "Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial"

    -BMJ Publication

  • "Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial"

    -BMJ Publication

  • "Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices"

    -Quality of Life Research Publication

  • "Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling"

    -Expert review of pharmacoeconomics & outcomes research publication

  • "Sunitinib treatment modification in first-line metastatic renal cell carcinoma: analysis of the STAR-TOR registry"

    -Anticancer Research

  • "Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses"

    -BMC Cancer Publication

  • "Improving patient-clinician communication following nephrectomy in renal cell carcinoma: Development, content validation and pilot testing of a conversation aid tool"

    -Patient Education and Counseling Publication

  • "Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe"

    -Plos one Publication

  • "The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe"

    -BMC Gastroenterology

  • "Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs"

    -Journal of Medical Economics Publication

  • "Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis"

    -BMJ open gastroenterology

  • "Real-world effectiveness of advanced therapies among patients with moderate to severe ulcerative colitis in the United States"

    -Inflammatory bowel diseases publication

  • "Cost-effectiveness of tofacitinib compared with Infliximab, Adalimumab, Golimumab and Vedolizumab for the treatment of moderate to severe ulcerative colitis in Germany"

    -ISPOR Abstract

  • "Using electronic health record data to identify comparator populations for comparative effectiveness research"

    -Journal of Medical Economics Publication

  • "Can Early US Adoption of Cancer Drugs Inform HTA Decision-Making?"

    ISPOR Poster

  • "Enhanced Cost-Effectiveness Analysis Using EHR Data for Real World Value"

    ISPOR Poster

  • "Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer"

    Value in Health Publication

  • "Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use"

    Inflammatory Intestinal Diseases Publication

  • "Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis"

    Digestive Diseases Publication

  • "Exploring the Potential for EHR-Derived Real-World Data to Reduce Uncertainty in HTA Decision-Making: A Case Study of Long-Term Survival Outcomes"

    ISPOR Oral Presentation